ASSET | DATE | % RETURN |
---|---|---|
Celsius (CELH) | 7/1/2014 - 7/31/2015 | 298.38% |
Neurocrine Biosciences (NBIX) | 7/1/2014 - 7/31/2015 | 236.15% |
Coca-Cola Consolidated (COKE) | 7/1/2014 - 7/31/2015 | 143.35% |
CyberArk Software (CYBR) | 7/1/2014 - 7/31/2015 | 136.52% |
Biomarin Pharmaceutical (BMRN) | 7/1/2014 - 7/31/2015 | 133.29% |
Genmab A-S (GMAB) | 7/1/2014 - 7/31/2015 | 123.36% |
Palo Alto Networks (PANW) | 7/1/2014 - 7/31/2015 | 120.62% |
Paycom Soft (PAYC) | 7/1/2014 - 7/31/2015 | 118.88% |
Monster Beverage (MNST) | 7/1/2014 - 7/31/2015 | 116.6% |
DexCom (DXCM) | 7/1/2014 - 7/31/2015 | 112% |
Axon Enterprise (AXON) | 7/1/2014 - 7/31/2015 | 103.9% |
Skyworks Solutions (SWKS) | 7/1/2014 - 7/31/2015 | 103.85% |
Builders FirstSource (BLDR) | 7/1/2014 - 7/31/2015 | 102.15% |
Alnylam Pharmaceuticals (ALNY) | 7/1/2014 - 7/31/2015 | 101.69% |
Electronic Arts (EA) | 7/1/2014 - 7/31/2015 | 98.58% |
Norwegian Cruise Line (NCLH) | 7/1/2014 - 7/31/2015 | 96.78% |
Regeneron Pharmaceuticals (REGN) | 7/1/2014 - 7/31/2015 | 93.93% |
United Therapeutics (UTHR) | 7/1/2014 - 7/31/2015 | 90.06% |
Fortinet (FTNT) | 7/1/2014 - 7/31/2015 | 89.59% |
Manhattan Associates (MANH) | 7/1/2014 - 7/31/2015 | 87.94% |
Centene (CNC) | 7/1/2014 - 7/31/2015 | 85.04% |
Incyte (INCY) | 7/1/2014 - 7/31/2015 | 84.37% |
Ulta Beauty (ULTA) | 7/1/2014 - 7/31/2015 | 81.2% |
NetEase (NTES) | 7/1/2014 - 7/31/2015 | 79.04% |
Edwards Lifesciences (EW) | 7/1/2014 - 7/31/2015 | 76.75% |